NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme

Completed · Phase 2

Conditions studied: Brain and Central Nervous System Tumors

In brief

RATIONALE: NBI-3001 may be able to locate cancer cells and stop them from growing. This may be an effective treatment for glioblastoma multiforme. PURPOSE: Randomized phase II trial to compare different regimens of NBI-3001 followed by surgery to remove the tumor in treating patients who have glioblastoma multiforme.

Key facts

Study ID

NCT00014677

Run by

Neurocrine Biosciences

Starts

2001-03-01

Expected to finish

2008-07-01

Last updated by the study team

2013-07-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• UCSD Thornton Hospital — La Jolla, California, United States
• Emory University Hospital - Atlanta — Atlanta, Georgia, United States
• St. Louis University Health Sciences Center — St Louis, Missouri, United States
• Charlotte Neurosurgical Associates — Charlotte, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.